How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

738 results for

Sibutramine

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

561. A systematic review of the clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity (Full text)

A systematic review of the clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

2002 NIHR HTA programme PubMed abstract

562. Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight or obese adults

Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight or obese adults Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight or obese adults | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please (...) see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: dietary plus pharmacological intervention (orlistat or sibutramine) induces long term weight loss in overweight

2007 Evidence-Based Nursing

563. Sibutramine: a review of its contribution to the management of obesity

Sibutramine: a review of its contribution to the management of obesity Sibutramine: a review of its contribution to the management of obesity Sibutramine: a review of its contribution to the management of obesity McNeely W, Goa K L Authors' objectives To review the contribution of sibutramine to the management of obesity. Searching Medical literature published in any language since 1966 identified using AdisBase (a proprietary database of Adis International, Auckland, New Zealand), MEDLINE (...) and EMBASE. Search terms used on all databases were 'sibutramine' and 'obesity'. Additional references were identified from the reference lists of published articles. Bibliographical information, including contributory unpublished data, was also requested from the company developing the drug. Study selection Study designs of evaluations included in the review Study designs reported in the review include double-blind, randomised controlled trials (RCTs). When available, large, well controlled trials

1998 DARE.

564. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment

The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G Authors' objectives To assess systematically the clinical effectiveness and cost (...) - effectiveness of sibutramine in the management of obesity. Searching Nineteen electronic databases were searched from inception to June 2000. These databases included MEDLINE, BIOSIS Previews, EMBASE, CINAHL and other topic-specific databases and citation indices. An extensive search strategy was reported in the appendices of the report. The authors also carried out Internet searches, checked the bibliographies of included papers for additional relevant studies, and received a submission of evidence from

2002 DARE.

565. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment

The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G Record Status This is a bibliographic record of a published health technology assessment (...) from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. Health Technology Assessment 2002; 6(6): 1-97 Authors' objectives This review aims to assess systematically the clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity. Authors

2002 Health Technology Assessment (HTA) Database.

566. Guidance on the use of sibutramine for the treatment of obesity in adults

Guidance on the use of sibutramine for the treatment of obesity in adults Guidance on the use of sibutramine for the treatment of obesity in adults Guidance on the use of sibutramine for the treatment of obesity in adults National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical Excellence (...) . Guidance on the use of sibutramine for the treatment of obesity in adults. London: National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 31. 2001 Authors' objectives To provide guidance on the use of sibutramine for the treatment of obesity in adults. Authors' conclusions Guidance 1.1 Sibutramine should be prescribed only as part of an overall treatment plan for management of nutritional obesity in people aged 18-65 years who meet one of the following criteria: 1.1.1 a body

2001 Health Technology Assessment (HTA) Database.

567. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. (Abstract)

Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Antiobesity treatment is recommended for selected patients in whom lifestyle modification is unsuccessful. Two antiobesity drugs are currently licensed for long-term use. Orlistat, a gastrointestinal lipase inhibitor, reduces weight by around 3 kg on average and decreases progression to diabetes in high-risk patients; adverse gastrointestinal effects are common. Sibutramine, a monoamine-reuptake inhibitor, results in mean

2007 Lancet

568. Is there any contraindication to sibutramine or orlistat in a female patient with mild porphyria variagata?

Is there any contraindication to sibutramine or orlistat in a female patient with mild porphyria variagata? Is there any contraindication to sibutramine or orlistat in a female patient with mild porphyria variagata? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere (...) clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any contraindication to sibutramine or orlistat in a female patient with mild porphyria variagata? We have found nothing that states sibutramine or orlistat are contraindicated

2006 TRIP Answers

569. Is there any evidence to suggest that any of the antiobesity drugs (orlistat, sibutramine or rimomabant) are effective as sole intervention for weight loss ie without combined dietary and / or lifesty

Is there any evidence to suggest that any of the antiobesity drugs (orlistat, sibutramine or rimomabant) are effective as sole intervention for weight loss ie without combined dietary and / or lifesty Is there any evidence to suggest that any of the antiobesity drugs (orlistat, sibutramine or rimomabant) are effective as sole intervention for weight loss ie without combined dietary and / or lifestyle interventions? - Trip Database or use your Google+ account Turning Research Into Practice ALL (...) @tripdatabase.com Is there any evidence to suggest that any of the antiobesity drugs (orlistat, sibutramine or rimomabant) are effective as sole intervention for weight loss ie without combined dietary and / or lifestyle interventions? This question presented problems in the literature searching stage as as our usual information sources do not permit restricting to sole rather than combined interventions. It would appear from our literature search that these antiobesity drugs have generally be evaluated as part

2007 TRIP Answers

570. Is there any reason not to co-prescribe rimonabant and sibutramine for weight loss?

Is there any reason not to co-prescribe rimonabant and sibutramine for weight loss? Is there any reason not to co-prescribe rimonabant and sibutramine for weight loss? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches (...) types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any reason not to co-prescribe rimonabant and sibutramine for weight loss? This is a question which we cannot answer with any confidence. We found no guidelines supporting this co-prescribing and we certainly

2007 TRIP Answers

571. Can sibutramine and orlistat be combined in severe cases of obesity?

Can sibutramine and orlistat be combined in severe cases of obesity? Can sibutramine and orlistat be combined in severe cases of obesity? - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top (...) information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Can sibutramine and orlistat be combined in severe cases of obesity? The CKS guideline on obesity considers the combination of sibutramine and orlistat and states: " There is evidence from one study to suggest that the addition of orlistat to sibutramine does

2008 TRIP Answers

572. Is there any evidence to support the use of sibutramine as an antidepressant?

Is there any evidence to support the use of sibutramine as an antidepressant? Is there any evidence to support the use of sibutramine as an antidepressant? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing (...) including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is there any evidence to support the use of sibutramine as an antidepressant? In 2001 NHS Tayside published a prescribing review of sibutramine [1], reporting: “Sibutramine is a new anti-obesity agent, which at first glance seems

2008 TRIP Answers

573. Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients

Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00729963 Recruitment Status : Completed First Posted : August 8, 2008 Last Update Posted : April 11

2008 Clinical Trials

574. Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00645255 Recruitment Status : Terminated First Posted : March 27, 2008 Last Update Posted : March 27, 2008

2008 Clinical Trials

575. Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00677391 Recruitment Status : Completed First Posted : May 14, 2008 Last Update Posted : May 14, 2008 Sponsor: Abbott Information provided

2008 Clinical Trials

576. Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have (...) reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives (HOS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00679653

2008 Clinical Trials

577. Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00533481 Recruitment Status : Completed First Posted : September 21, 2007 Last Update Posted : September 16, 2016 Sponsor: Merck Sharp & Dohme Corp

2007 Clinical Trials

578. Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00463112 Recruitment Status : Completed First Posted : April 20, 2007 Last Update Posted

2007 Clinical Trials

579. Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Pharmacodynamic (...) Effects of Sibutramine on Gastric Function in Obesity The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00330525 Recruitment Status : Completed First Posted : May 29, 2006 Last Update Posted : January 20, 2010 Sponsor: Mayo Clinic Information provided by: Mayo Clinic Study Details Study Description Go

2006 Clinical Trials

580. A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00261911 Recruitment Status : Completed First Posted : December 6, 2005 Last Update Posted : August 31, 2007 Sponsor: Abbott Information provided by: Abbott

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>